114 related articles for article (PubMed ID: 11914043)
1. IPF-1 gene variation and the development of type 2 diabetes.
Silver K; Shetty A
Mol Genet Metab; 2002 Mar; 75(3):287-9. PubMed ID: 11914043
[TBL] [Abstract][Full Text] [Related]
2. Missense mutations in the human insulin promoter factor-1 gene and their relation to maturity-onset diabetes of the young and late-onset type 2 diabetes mellitus in caucasians.
Hansen L; Urioste S; Petersen HV; Jensen JN; Eiberg H; Barbetti F; Serup P; Hansen T; Pedersen O
J Clin Endocrinol Metab; 2000 Mar; 85(3):1323-6. PubMed ID: 10720084
[TBL] [Abstract][Full Text] [Related]
3. Insulin Promoter Factor 1 variation is associated with type 2 diabetes in African Americans.
Karim MA; Wang X; Hale TC; Elbein SC
BMC Med Genet; 2005 Oct; 6():37. PubMed ID: 16229747
[TBL] [Abstract][Full Text] [Related]
4. Mutations in the insulin promoter factor-1 gene in late-onset type 2 diabetes mellitus.
Reis AF; Ye WZ; Dubois-Laforgue D; Bellanné-Chantelot C; Timsit J; Velho G
Eur J Endocrinol; 2000 Oct; 143(4):511-3. PubMed ID: 11022198
[TBL] [Abstract][Full Text] [Related]
5. Missense mutations in the human insulin promoter factor-1 gene are not a common cause of type 2 diabetes mellitus in Taiwan.
Shiau MY; Huang CN; Liao JH; Chang YH
J Endocrinol Invest; 2004 Dec; 27(11):1076-80. PubMed ID: 15754742
[TBL] [Abstract][Full Text] [Related]
6. Missense mutations in the insulin promoter factor-1 gene predispose to type 2 diabetes.
Macfarlane WM; Frayling TM; Ellard S; Evans JC; Allen LI; Bulman MP; Ayres S; Shepherd M; Clark P; Millward A; Demaine A; Wilkin T; Docherty K; Hattersley AT
J Clin Invest; 1999 Nov; 104(9):R33-9. PubMed ID: 10545530
[TBL] [Abstract][Full Text] [Related]
7. Hepatocyte nuclear factor-6: associations between genetic variability and type II diabetes and between genetic variability and estimates of insulin secretion.
Møller AM; Ek J; Durviaux SM; Urhammer SA; Clausen JO; Eiberg H; Hansen T; Rousseau GG; Lemaigre FP; Pedersen O
Diabetologia; 1999 Aug; 42(8):1011-6. PubMed ID: 10491763
[TBL] [Abstract][Full Text] [Related]
8. Does the aspartic acid to asparagine substitution at position 76 in the pancreas duodenum homeobox gene (PDX1) cause late-onset type 2 diabetes?
Elbein SC; Karim MA
Diabetes Care; 2004 Aug; 27(8):1968-73. PubMed ID: 15277425
[TBL] [Abstract][Full Text] [Related]
9. Functional consequences of mutations in the MODY4 gene (IPF1) and coexistence with MODY3 mutations.
Weng J; Macfarlane WM; Lehto M; Gu HF; Shepherd LM; Ivarsson SA; Wibell L; Smith T; Groop LC
Diabetologia; 2001 Feb; 44(2):249-58. PubMed ID: 11270685
[TBL] [Abstract][Full Text] [Related]
10. Isolation of the human LIM/homeodomain gene islet-1 and identification of a simple sequence repeat polymorphism [corrected].
Tanizawa Y; Riggs AC; Dagogo-Jack S; Vaxillaire M; Froguel P; Liu L; Donis-Keller H; Permutt MA
Diabetes; 1994 Jul; 43(7):935-41. PubMed ID: 7912209
[TBL] [Abstract][Full Text] [Related]
11. Defective mutations in the insulin promoter factor-1 (IPF-1) gene in late-onset type 2 diabetes mellitus.
Hani EH; Stoffers DA; Chèvre JC; Durand E; Stanojevic V; Dina C; Habener JF; Froguel P
J Clin Invest; 1999 Nov; 104(9):R41-8. PubMed ID: 10545531
[TBL] [Abstract][Full Text] [Related]
12. Analysis of FOXO1A as a candidate gene for type 2 diabetes.
Karim MA; Craig RL; Wang X; Hale TC; Elbein SC
Mol Genet Metab; 2006 Jun; 88(2):171-7. PubMed ID: 16497530
[TBL] [Abstract][Full Text] [Related]
13. Insulin promoter factor 1 gene is not a major cause of maturity-onset diabetes of the young in French Caucasians.
Chèvre JC; Hani EH; Stoffers DA; Habener JF; Froguel P
Diabetes; 1998 May; 47(5):843-4. PubMed ID: 9588460
[No Abstract] [Full Text] [Related]
14. Association of the distal region of the ectonucleotide pyrophosphatase/phosphodiesterase 1 gene with type 2 diabetes in an African-American population enriched for nephropathy.
Keene KL; Mychaleckyj JC; Smith SG; Leak TS; Perlegas PS; Langefeld CD; Freedman BI; Rich SS; Bowden DW; Sale MM
Diabetes; 2008 Apr; 57(4):1057-62. PubMed ID: 18184924
[TBL] [Abstract][Full Text] [Related]
15. The interleukin-6 (-174) G/C promoter polymorphism is associated with type-2 diabetes mellitus in Native Americans and Caucasians.
Vozarova B; Fernández-Real JM; Knowler WC; Gallart L; Hanson RL; Gruber JD; Ricart W; Vendrell J; Richart C; Tataranni PA; Wolford JK
Hum Genet; 2003 Apr; 112(4):409-13. PubMed ID: 12589429
[TBL] [Abstract][Full Text] [Related]
16. Sequencing PDX1 (insulin promoter factor 1) in 1788 UK individuals found 5% had a low frequency coding variant, but these variants are not associated with Type 2 diabetes.
Edghill EL; Khamis A; Weedon MN; Walker M; Hitman GA; McCarthy MI; Owen KR; Ellard S; T Hattersley A; Frayling TM
Diabet Med; 2011 Jun; 28(6):681-4. PubMed ID: 21569088
[TBL] [Abstract][Full Text] [Related]
17. IPF-1/MODY4 gene missense mutation in an Italian family with type 2 and gestational diabetes.
Gragnoli C; Stanojevic V; Gorini A; Von Preussenthal GM; Thomas MK; Habener JF
Metabolism; 2005 Aug; 54(8):983-8. PubMed ID: 16092045
[TBL] [Abstract][Full Text] [Related]
18. Insulin receptor substrate-1 gene variants in lipoatrophic diabetes mellitus and non-insulin-dependent diabetes mellitus: a study of South African black and white subjects.
Panz VR; Raal FJ; O'Rahilly S; Kedda MA; Joffe BI
Hum Genet; 1997 Nov; 101(1):118-9. PubMed ID: 9385382
[No Abstract] [Full Text] [Related]
19. Polymorphism of the thiopurine S-methyltransferase gene in African-Americans.
Hon YY; Fessing MY; Pui CH; Relling MV; Krynetski EY; Evans WE
Hum Mol Genet; 1999 Feb; 8(2):371-6. PubMed ID: 9931346
[TBL] [Abstract][Full Text] [Related]
20. [Association of polymorphism in neurogenic differentiation factor 1 gene with type 2 diabetes].
Ye L; Xu Y; Zhu Y; Fan Y; Deng H; Zhang J
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2002 Dec; 19(6):484-7. PubMed ID: 12476420
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
